HedgeChatter

  • Home /
  • Tag Archives

ENTA

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2014

[Business Wire] – Enanta Pharmaceuticals, Inc., , a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, to moreView todays social media effects on ENTAView the latest stocks trending across Twitter. Click to view dashboardSee who Enanta is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2014 read more

Enanta Pharmaceuticals Announces the Appointment of Nathaniel S. Gardiner, J.D. as Senior Vice President and General Counsel

[Business Wire] – Enanta Pharmaceuticals, Inc. a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced the appointment of Nathaniel S. moreView todays social media effects on ENTAView the latest stocks trending across Twitter. Click to view dashboardSee who Enanta is hiring next, click here to view […]

May 12, 2014 Bystocknews , Comments Off on Enanta Pharmaceuticals Announces the Appointment of Nathaniel S. Gardiner, J.D. as Senior Vice President and General Counsel read more

ARIAD’s Q1 Loss Narrows

moreView todays social media effects on ENTAView the latest stocks trending across Twitter. Click to view dashboardSee who Enanta is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on ARIAD’s Q1 Loss Narrows read more

Enanta Pharmaceuticals Announces Submission of EU Marketing Authorization Applications to the European Medicines Agency for All-Oral, Interferon-Free Hepatitis C Regimen Containing ABT-450

[Business Wire] – Enanta Pharmaceuticals, Inc. , a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, tod moreView todays social media effects on ENTAView the latest stocks trending across Twitter. Click to view dashboardSee who Enanta is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on Enanta Pharmaceuticals Announces Submission of EU Marketing Authorization Applications to the European Medicines Agency for All-Oral, Interferon-Free Hepatitis C Regimen Containing ABT-450 read more

AbbVie Submits for EU Marketing Authorization its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Chronic Hepatitis C

[PR Newswire] – NORTH CHICAGO, Ill., May 8, 2014 /PRNewswire/ — AbbVie (ABBV) submitted marketing authorization applications (MAAs) to the European Medicines Agency (EMA) seeking approval for the company’s investigational, all-oral, interferon-free regi moreView todays social media effects on ENTAView the latest stocks trending across Twitter. Click to view dashboardSee who Enanta is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on AbbVie Submits for EU Marketing Authorization its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Chronic Hepatitis C read more